MedPath

Cross-sectional study for the relationship between nighttime sleep duration, midday naps and type2 diabetes

Not Applicable
Recruiting
Conditions
type 2 diabetes, IGT
Registration Number
JPRN-UMIN000017887
Lead Sponsor
Osaka Gyomeikan Hospital
Brief Summary

Poor sleep quality and quantity could aggravate glycemic control (HbA1c>7%) in type 2 diabetes. Midday naps could mitigate the deleterious effects of short nighttime sleep (<5 h) on glycemic control.

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
398
Inclusion Criteria

Not provided

Exclusion Criteria

advanced renal dysfunction (serum creatinine>2.0 mg/dL), chronic hepatic and cardiopulmonary disease

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
FPG, serum HbA1c, C-peptide, lipids, albuminuria and blood pressure in each subgroup with different nighttime sleep duration/quality with or without midday naps
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath